Close

Drug Research

AGC Biologics, Asahi Kasei Enter Clinical Drug Substance Agreement

AGC Biologics, a global biopharmaceutical CDMO, entered a new agreement with Asahi Kasei Pharma to produce clinical drug substance for antibody-based therapies at AGC Biologics’ Seattle manufacturing site.AGC Biologics will leverage its monoclonal antibody development and manufacturing experience to...

Chiesi, Aliada Therapeutics Enter Drug Delivery Alliance

Chiesi Global Rare Diseases has entered a co-development agreement with Aliada Therapeutics, a biotechnology company developing a novel blood-brain barrier (BBB)-crossing platform technology to address challenging disease areas with high unmet need.The collaboration will focus on multiple enzyme cargoes...

Croda Pharma introduces new bioprocessing solutions to replace banned materials

Croda Pharma has introduced a critical range of new bioprocessing detergents optimised for viral inactivation and cell lysis. The company’s new product range, Virodex™, offers an answer to the key market need for replacing the popular, but now banned,...

The Rise of mRNA Technology In Parenteral Drug Manufacturing

The parenteral drug manufacturing process is anchored by the Supply Chain. The impact of COVID-19 has influenced both positively and negatively the production of contemporary parenteral drugs. Many manufacturers have structured their systems around the lean Just-In-Time (JIT) production...

Lonza Launches Nebula Absorbance Reader for Streamlined Endotoxin and Pyrogen Testing

Lonza has launched the Nebulaยฎ Absorbance Reader, a new absorbance microplate reader which joins the companyโ€™s portfolio of optimized instruments for streamlined endotoxin and pyrogen testing. Pharmaceutical quality control (QC) laboratories worldwide rely on the traditional absorbance-basedย Limulusย amebocyte lysate (LAL) andย Tachypleusย amebocyte...

Emerging Markets Drive Small Molecule API Market Expansion

As per insights, a significant increase in the small molecule active pharmaceutical ingredient (API) market has been projected, estimating it to be valued at approximately $284.7 billion by 2032, compared to $162.8 billion in 2022. A compound annual growth...

Startups Tackle Efficiency Woes In The Pharma Supply Chain

The healthcare industry is responsible for 4.4% of all greenhouse gas emissions and faces significant challenges in its supply chain, resulting in $35 billion worth of wasted products each year. Startups have emerged as powerful agents of change, leveraging...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป